Abbott Laboratories (NYSE:ABT) concluded the trading at $104.82 on Wednesday, May 22, with a rise of 1.81% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $102.96. Company’s P/E ratio for the trailing 12 months is 32.65. Considering stock’s 52-week price range provides that ABT hit a high price of $121.64 and saw its price falling to a low level of $89.67 during that period. Over a period of past 1-month, stock came subtracting -2.57% in its value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
With its current market valuation of $182.35 billion. ABT Stock’s Forward Dividend of 2.12 and its yield of 2.02% are making investors’ thoughts stronger that it could climb further before the company announces its earnings for the current quarter.
In contrast, when we review ABT stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of Hold. Long term indicators are suggesting an average of 50% Sell for it.
Digging deeper we become aware of the PEG ratio of the ABT stock which is currently positioned at 4.03. It further provides that stock’s current price level is -0.52% away from its 20-day simple moving average and is -3.89% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 43.24 while volatility remained at 1.23% over the past week which changes to 1.20% when measuring it over the past month. Beta is valued at 0.74, while measure of average true range or ATR is currently at 1.49.
Having a second look at Abbott Laboratories (NYSE:ABT) provides that stock’s average daily trading volume for 3 months was 5.70 million. Number of outstanding shares of the stock stood at 1.73 billion.
The percentage of outstanding shares held by the insiders is 0.72% while it is 77.17% for the institutional holders. Subtraction of -4.77% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
